Bio-Rad Laboratories, Inc.Class A vs. Waters Corp
Bio-Rad Laboratories, Inc.Class A (BIO) comes out ahead, leading on 2 of 3 compared factors.
Size & Scale
| BIO | WAT | |
|---|---|---|
| Market Cap | $10.21 billion | $40.35 billion |
| Revenue (TTM) | $2.59 billion | — |
| Net Income (TTM) | $222.40 million | — |
WAT leads on 1 of 1 size & scale factors.
Valuation
| BIO | WAT | |
|---|---|---|
| P/E Ratio | 46.50 | — |
| Price / Book | 1.42 | 2.66 |
| Price / Sales | 3.94 | — |
BIO leads on 1 of 1 valuation factors.
Profitability
| BIO | WAT | |
|---|---|---|
| Net Margin | 8.59% | — |
| Return on Equity | 3.10% | — |
BIO and WAT split the profitability factors evenly.
Risk & Sentiment
| BIO | WAT | |
|---|---|---|
| Short Interest | 2.44% | 3.23% |
BIO leads on 1 of 1 risk & sentiment factors.
Dig deeper: BIO overview, BIO financials, WAT overview, WAT financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.